Pharma Mar, S.A. (BME: PHM)

Pharma Mar Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	34.8	60.02	149.81	113.35	96.21	17.64
Short-Term Investments	109.59	102.54	32.61	88.53	99.31	3.26
Cash & Short-Term Investments	144.39	162.56	182.42	201.88	195.52	20.9
Cash Growth	-17.18%	-10.89%	-9.64%	3.25%	835.71%	-22.25%
Accounts Receivable	33.7	27.55	29.32	50.91	24.05	11.53
Receivables	33.7	27.55	29.32	50.91	24.05	11.53
Inventory	47.76	39.29	27.75	10.54	11.93	8.9
Prepaid Expenses	-	2.92	5.98	3.91	1	1.34
Other Current Assets	12.17	20.28	29.71	28	13.15	7.31
Total Current Assets	238.02	252.6	275.18	295.23	245.65	49.98
Property, Plant & Equipment	57.67	34.54	33.23	26.9	24.75	25.6
Long-Term Investments	3.78	6.06	49.4	10.72	20.99	1.03
Other Intangible Assets	1.24	1.23	1.19	1.13	0.99	0.86
Long-Term Deferred Tax Assets	31.58	31.47	30.53	27.75	33.42	40.98
Long-Term Deferred Charges	-	0.7	1.4	2.11	2.81	5.15
Other Long-Term Assets	0.85	13.91	2.33	4.55	1.67	1.11
Total Assets	333.13	340.52	393.26	368.39	330.26	124.71
Accounts Payable	35.2	29.17	27.49	26.93	21.04	16.47
Accrued Expenses	9.6	12.39	10.44	9.5	8.79	7.66
Short-Term Debt	-	6.72	4.48	3.84	4.77	13.82
Current Portion of Long-Term Debt	9.86	6.11	8.64	8.37	10.54	15.83
Current Portion of Leases	1.39	1.98	1.61	1.82	1.47	1.68
Current Unearned Revenue	9.98	25.95	26.11	30.89	44.71	3.12
Other Current Liabilities	23.42	13.57	18.54	4.99	3.61	1.85
Total Current Liabilities	89.44	95.89	97.32	86.35	94.92	60.44
Long-Term Debt	40.98	27.04	25.88	33.39	37.73	53.06
Long-Term Leases	1.25	1.83	2.01	1.92	2.15	1.72
Long-Term Unearned Revenue	19.09	22.14	44.9	68.63	92.56	1.85
Other Long-Term Liabilities	0.2	0.19	0.19	0.19	0.18	0.18
Total Liabilities	150.96	147.08	170.3	190.47	227.54	117.25
Common Stock	11.01	11.01	11.01	11.01	11.01	11.13
Additional Paid-In Capital	59.86	71.28	71.28	71.28	71.28	71.28
Retained Earnings	148.42	142.22	156.51	121.29	41.87	-69.55
Treasury Stock	-37.13	-31.09	-15.87	-25.68	-21.45	-1.5
Comprehensive Income & Other	0.02	0.02	0.02	0.02	0.01	0.02
Total Common Equity	182.17	193.44	222.96	177.92	102.72	11.37
Minority Interest	-	-	-	-	-	-3.92
Shareholders' Equity	182.17	193.44	222.96	177.92	102.72	7.46
Total Liabilities & Equity	333.13	340.52	393.26	368.39	330.26	124.71
Total Debt	53.48	43.67	42.63	49.33	56.67	86.12
Net Cash (Debt)	90.92	118.89	139.79	152.55	138.85	-65.22
Net Cash Growth	-30.48%	-14.95%	-8.36%	9.86%	-	-
Net Cash Per Share	5.18	6.64	7.74	8.44	7.58	-3.53
Filing Date Shares Outstanding	17.54	17.64	18.11	18.01	18.11	18.5
Total Common Shares Outstanding	17.54	17.64	18.11	18.01	18.11	18.5
Working Capital	148.58	156.71	177.86	208.89	150.73	-10.46
Book Value Per Share	10.39	10.97	12.31	9.88	5.67	0.61
Tangible Book Value	180.93	192.2	221.77	176.79	101.74	10.52
Tangible Book Value Per Share	10.32	10.90	12.25	9.82	5.62	0.57
Land	-	29.04	29.04	22.59	21.99	21.99
Machinery	-	23.96	27.87	24.32	21.51	21.74

Source: S&P Capital IQ. Standard template. Financial Sources.